Souad Aboudkhil

Souad Aboudkhil

Auto-generated profile, based on publicly available information

Souad Aboudkhil

Hassan II University of Casablanca, Laboratory of Biotechnology, Agri-Food, Materials and Environment, Faculty of Science and Technology Mohammedia, BP 146, Mohammedia 20650, Morocco (ROR: https://ror.org/001q4kn48)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2021 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
OYOuadie Mohamed El Yaagoubi
Ouadie Mohamed El Yaagoubi
Larbi OularbiLarbi Oularbi
Larbi Oularbi
Abdelhakim BOUYAHYAAbdelhakim BOUYAHYA
Abdelhakim BOUYAHYA
HSHamid Samaki
Hamid Samaki
SASaid El Antri
Said El Antri
SASouad Aboudkhil
Souad Aboudkhil
The Ubiquitin-Proteasome System plays a central role in signal transduction associated with stress, in the skin in particular by the control of NF-κB pathways. Under normal conditions, the inhibitory protein IκB is phosphorylated by kinases, then ubiquitinated and ends up at the proteasome to be degraded. The present short review discusses recent progress in the inhibition of NF-κB activation by proteasome inhibitors prevents the degradation of protein IκB, which accumulates in the cytosol, and there by the activation of NF-κB. Moreover, would not only limit the expression of adhesion molecules and cytokines involved in metastatic processes, but also increase the sensitivity of cancer cells to apoptosis. Considering this fact, the activity of NF-κB is regulated by the phosphorylation and proteasome-dependent degradation of its inhibitor Iκb. In this scenario, the use of a proteasome inhibitor might be an effective strategy in the treatment of skin cancer with constitutive activation of NF-κB.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
OYOuadie Mohamed El Yaagoubi
Ouadie Mohamed El Yaagoubi
ALAyoub Lahmadi
Ayoub Lahmadi
Abdelhakim BOUYAHYAAbdelhakim BOUYAHYA
Abdelhakim BOUYAHYA
HFHassan Filali
Hassan Filali
HSHamid Samaki
Hamid Samaki
SASouad Aboudkhil
Souad Aboudkhil
The aim of this work is to evaluate the antitumor effect mediated by the proteasome inhibitors of Inula viscosa extracts on skin carcinogenesis. Female Swiss albino mice were divided into five groups depending on the combination of skin cancer‐inducing 7,12‐dimethylbenz(a)anthracene (DMBA) and extract of Inula viscosa treatments. Histology of the affected skin and measurement of proteasome activity were performed to demonstrate the effect of Inula viscosa on mice. The identification of the molecules responsible for this inhibitory activity was carried out through the docking studies. The results showed that Inula viscosa extracts inhibit the development of papilloma in mice. Therefore, the best chemopreventive action of Inula viscosa was observed on mice in which extract treatment was performed before and after the induction of skin carcinogenesis. It was revealed that the ingestion of extracts Inula viscosa delays the formation of skin papillomas in animals and simultaneously decreases the size and number of papillomas, which is also reflected on the skin histology of the mice treated. Structure–activity relationship information obtained from component of Inula viscosa particularly tomentosin, inuviscolide, and isocosticacid demonstrated that distinct bonding modes in β1, β2, and β5 subunits determine its selectivity and potent inhibition for β5 subunit.

17 April 2026 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
SBSidi Mohamed Cheikh Bouna
Sidi Mohamed Cheikh Bouna
NANabil Said Abdellah
Nabil Said Abdellah
HKHabiba Kamal
Habiba Kamal
MHMohamed Hemeyine
Mohamed Hemeyine
AHAhmed Houmeida
Ahmed Houmeida
SASouad Aboudkhil
Souad Aboudkhil
Mauritania has a high prevalence of chronic hepatitis B virus (HBV) and hepatitis D virus (HDV), posing a major public health burden. A comprehensive analysis of seroprevalence, transmission dynamics, and molecular epidemiology would help inform strategies for public health interventions. This study systematically reviews the published literature in the field between 1983 and 2024, employing PRISMA 2020 guidelines. Where insufficient data were available for meta-analyses on specific inquiries, summative descriptions were included. Eight studies involving 19,781 participants were included. The pooled HBsAg seroprevalence was 15.2% (95% CI: 12.8%–18.0%; I 2 = 91.9%; p < 0.0001 ) by meta-analysis. Among HBV-exposed individuals, male sex, lower education levels, and certain occupations were more commonly observed. Genotype D dominated HBV strains (50%), followed by E (36.2%), A (12%), and G (0.5%). Among 1739 HBsAg-positive individuals from five studies, the seroprevalence of anti-HDV antibodies was 21.2% (95% CI, 14.7%—29.4%; I 2 = 94.1%; p < 0.0001 ), with HDV-RNA detectable in 52.0% of cases. Occupation and geographic location were more commonly observed among HDV-infected individuals. HDV-1 was the predominant genotype (89.3%), followed by HDV-5 (10.7%). Given the dual epidemic of HBV and HDV faced by Mauritania, targeted public health strategies will be needed. This systematic review and meta-analysis outlines some of the known epidemiology, both molecular and social, to aid the focus of public health programs.

7 June 2026 in Natural Built Social Environment Health
Verified
Journal Article
Open access
PDF file
KMKholoud Maafi
Kholoud Maafi
HAHamza Abidar
Hamza Abidar
KSKarim Souly
Karim Souly
SASouad Aboudkhil
Souad Aboudkhil
This study evaluated the performance of the GeneXpert MTB/RIF® test (Cepheid Inc., USA) for detecting Mycobacterium tuberculosis and Rifampicin resistance in pericardial tuberculosis (TBP), compared to culture, the reference method recommended by the Moroccan National Tuberculosis Control Programme (PNLAT). Conducted prospectively over 36 months, the study analysed 27 pericardial fluid samples from suspected TBP cases at Ibn Sina University Hospital, Rabat. Conventional methods (bacilloscopy and culture) were compared to GeneXpert MTB/RIF. Microscopy showed no positive results, whereas GeneXpert MTB/RIF and culture yielded positivity rates of 14.81% and 11.11%, respectively. Most culture-positive samples were bacilloscopy-negative. The GeneXpert MTB/RIF assay showed 100% sensitivity and NPV, with 95.8% specificity and 75% PPV. No Rifampicin resistance was identified. The findings suggest that GeneXpert MTB/RIF is a rapid and reliable first-line diagnostic tool for pericardial tuberculosis and may replace smear microscopy and culture, which require prolonged incubation.

27 October 2025 in Natural Built Social Environment Health
Verified
Journal Article
Open access
PDF file
KMKholoud Maafi
Kholoud Maafi
INIsmail Nafi
Ismail Nafi
HAHamza Abidar
Hamza Abidar
FLFirdaous Laariche
Firdaous Laariche
MNMarwa Nabil
Marwa Nabil
SASouad Aboudkhil
Souad Aboudkhil
This study assesses the performance of the GeneXpert MTB/RIF® test (Cepheid Inc., Sunnyvale, CA, USA) for detecting Mycobacterium tuberculosis and Rifampicin resistance (RR) in Morocco, in comparison with conventional methods such as culture, and contrasts the results with data from other African countries. Conducted over 36 months, the study analysed 4,465 biological samples from patients suspected of tuberculosis at Ibn Sina University Hospital in Rabat between January 2020 and January 2023. The positivity rates for smear microscopy, GeneXpert, and culture were 2.55% (n = 114), 14.49% (n = 647), and 3.27% (n = 146), respectively. Of all samples, 71.41% were negative for both tests, 11.97% were culture-positive but smear-negative, and 10.59% were positive for both. GeneXpert achieved a sensitivity of 92.45%, specificity of 89.06%, negative predictive value of 99.99%, and positive predictive value of 24.48%. Rifampicin resistance was detected in 2.94% (19 samples, including 17 sputum and two cerebrospinal fluid samples). This study emphasizes the value of GeneXpert as a rapid and reliable diagnostic tool for tuberculosis and resistance detection in high-burden contexts, with potential for broad application in developing countries.

7 October 2026 in Natural Built Social Environment Health
Verified
Journal Article
Open access
KMKholoud Maafi
Kholoud Maafi
ZAZakaria Asbai
Zakaria Asbai
KSKarim Souly
Karim Souly
SASouad Aboudkhil
Souad Aboudkhil
Cutaneous tuberculosis is a rare form of extrapulmonary tuberculosis. The diagnosis remains challenging because of its clinical polymorphism and low bacillary load. We report the case of a 19-year-old Moroccan woman receiving methotrexate for recently diagnosed rheumatoid arthritis who developed cutaneous tuberculosis in the deltoid region. Initial GeneXpert MTB/RIF analysis detected Mycobacterium tuberculosis without identifying rifampicin resistance, leading to first-line anti-tuberculosis treatment. Despite excellent adherence and multidisciplinary follow-up, the lesion progressively worsened. Repeat molecular testing with GeneXpert MTB/RIF Ultra and GeneXpert MTB/XDR revealed rifampicin monoresistance, subsequently confirmed by phenotypic drug susceptibility testing. Adjustment of the treatment regimen according to the resistance profile resulted in rapid clinical improvement and progressive lesion regression. This case highlights the diagnostic limitations of the first-generation GeneXpert MTB/RIF assay in paucibacillary cutaneous tuberculosis and emphasizes the value of next-generation molecular techniques for the early detection of anti-tuberculosis drug resistance, particularly in immunocompromised patients.